These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6393886)

  • 21. Platelet survival and function in animals with prosthetic mitral valve: the effect of nafazatrom.
    Al-Mondhiry H; Pierce WS; Richenbacher W
    Thromb Haemost; 1984 Oct; 52(2):99-101. PubMed ID: 6523440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro studies of thromboresistance: the role of prostacyclin (PGI2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells.
    Curwen KD; Gimbrone MA; Handin RI
    Lab Invest; 1980 Mar; 42(3):366-74. PubMed ID: 6244462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis.
    Srivastava R; Puri V; Srimal RC; Dhawan BN
    Arzneimittelforschung; 1986 Apr; 36(4):715-7. PubMed ID: 3521617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet aggregation induced in the hamster cheek pouch by a photochemical process with excited fluorescein isothiocyanate-dextran.
    Herrmann KS
    Microvasc Res; 1983 Sep; 26(2):238-49. PubMed ID: 6194418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prostacyclin on tumor cell-induced platelet aggregation.
    Menter DG; Onoda JM; Taylor JD; Honn KV
    Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of PGI2, CH-7284 and CH-7384 on spontaneous platelet aggregation and blood pressure of anaesthetized beagles.
    Hermán F; Malomvölgyi B; Hadházy P; Magyar K
    Biomed Biochim Acta; 1988; 47(10-11):S113-6. PubMed ID: 3073758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
    Kanayama T; Kimura Y; Iseki K; Hayashi Y; Tamao Y; Mizogami S
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1210-7. PubMed ID: 1702154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet interaction with a pancreatic ascites tumor.
    Hamilton J; Subbarao V; Granack K; Ts'ao C
    Am J Pathol; 1986 Jan; 122(1):160-8. PubMed ID: 3510553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity ratio between antiprostacyclin and antiaggregating effects of acetylsalicylic acid, indometacin and ditazole.
    Caprino L; Togna G; Antonetti F; Borrelli F
    Arzneimittelforschung; 1980; 30(3):406-9. PubMed ID: 6104493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of leukotriene B4 formation in human neutrophils after oral nafazatrom (Bay g 6575).
    Strasser T; Fischer S; Weber PC
    Biochem Pharmacol; 1985 Jun; 34(11):1891-4. PubMed ID: 2988560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed antiischemic effect of prostaglandin I2 and of a new stable prostaglandin I2 analogue, 7-oxo-prostacyclin-Na, in experimental model angina in dogs.
    Szekeres L; Krassói I; Pataricza J; Udvary E
    Adv Myocardiol; 1985; 6():607-18. PubMed ID: 3887531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of prostacyclin on platelet aggregation as studied with "filter-loop" technique in the flowing blood of the dog.
    Imai S; Matsubara I
    Artery; 1980; 8(1):63-72. PubMed ID: 7000043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nafazatrom (Bay g 6575) blunts canine hypoxic pulmonary vasoconstriction: evidence for a prostaglandin-mediated mechanism.
    Ensley RD; Rubin LJ
    Prostaglandins Leukot Med; 1985 Apr; 18(1):95-104. PubMed ID: 3923499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.
    Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J
    Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical pharmacology of acetylsalicylic acid].
    Schröder H; Schrör K
    Z Kardiol; 1992; 81 Suppl 4():171-5. PubMed ID: 1290295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of prostacyclin in vascular tissue.
    Moncada S; Vane JR
    Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of thrombin and platelets with the vascular endothelium.
    Hoak JC; Czervionke RL; Fry GL; Smith JB
    Fed Proc; 1980 Jul; 39(9):2606-9. PubMed ID: 6995153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function.
    Bednar M; Smith B; Pinto A; Mullane KM
    Circ Res; 1985 Jul; 57(1):131-41. PubMed ID: 2988818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.